Sustained IL-1α, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus
- 16 January 2008
- journal article
- research article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 9 (1) , 9-16
- https://doi.org/10.1111/j.1399-5448.2007.00243.x
Abstract
Objective: An imbalance of pro-/anti-inflammatory cytokines may accelerate diabetic vascular complications and interfere with proper wound healing. Currently, limited available literature suggests that plasma concentrations of certain pro- and anti-inflammatory cytokines may be altered during hyperglycemia/diabetes mellitus. It is still unclear, however, whether these concepts also apply to children with diabetes, and whether alterations in circulating cytokine levels are a permanent feature of diabetes or an acute effect of fluctuating glucose concentrations. Methods: Twenty-two children with type 1 diabetes mellitus (T1DM) were studied. In 13 children, postprandial morning plasma glucose was > 11.1 mmol/L at least once (hyperglycemic group, or HyG group); in 9 subjects, plasma glucose never exceeded 10.6 mmol/L (non-hyperglycemic group, or non-HyG group). After admission, intensive euglycemia (5.0-6.1 mmol/L) was achieved in all participants via intravenous insulin and dextrose for at least 90 min. Blood samples were drawn every 30 min to determine plasma levels of 14 cytokines and chemokines. Results: Interleukin IL-1 alpha, IL-4, and IL-6 were elevated in HyG group compared with non-HyG not only when plasma glucose was elevated but also during the first 2 h following return to euglycemia. The levels of the other 11 cytokines were not significantly different. Conclusion: Specific cytokines (IL-1 alpha, IL-4, and IL-6) are acutely elevated during hyperglycemia in children with T1DM, and these elevations persist for hours after hyperglycemia has been corrected. Therefore, aside from glycemic control, additional therapeutic measures against elevated proinflammatory signals may be necessary for preventing vascular complications in children with hyperglycemic diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Vascular complications in diabetes mellitus: the role of endothelial dysfunctionClinical Science, 2005
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002
- Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetesJournal of Internal Medicine, 2001
- Elevated Levels of Interleukin-6 in Young Adults With Type 1 Diabetes Without Clinical Evidence of Microvascular and Macrovascular ComplicationsDiabetes Care, 2001
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damageNature, 2000
- Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 ProductionThe Journal of Experimental Medicine, 1998
- Oxidative Stress and Diabetic Vascular ComplicationsDiabetes Care, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Blood Glucose Control and the Evolution of Diabetic Retinopathy and AlbuminuriaNew England Journal of Medicine, 1984